论文部分内容阅读
肿瘤病人化疗常因造血、消化、神经、泌尿等各系统出现毒性反应,使治疗延缓甚至被迫中止,影响了病人的预后。作者自1977年起对肿瘤病人应用皮质激素与抗癌药物联合化疗,收到了预防毒性反应的良好效果。一、临床资料病人共76例(按疗程计算)。其中男25例,女51例。乳腺癌23例,胃癌18例,小肠平滑肌肉瘤2例,胰腺癌1例,结肠癌11例,直肠癌18例,前列腺癌3例。年龄最小23岁,最大69岁。使用5-FU(1.0g/日)或FT-207(1200mg/日)其中一种抗癌药物与皮质激素联合化疗48例,使用VCR(1～2mg/日)、5-FU(1.0g/日)、FT-207(1200mg/日)、
Cancer patients often undergo toxic reactions due to hematopoietic, digestive, neurological, and urinary systems, delaying or even forcing treatment to stop, affecting the patient’s prognosis. Since 1977, the authors applied corticosteroids and anti-cancer drugs to cancer patients and received good results in the prevention of toxic reactions. First, the clinical data of a total of 76 patients (calculated according to treatment). There were 25 males and 51 females. There were 23 cases of breast cancer, 18 cases of gastric cancer, 2 cases of small intestine leiomyosarcoma, 1 case of pancreatic cancer, 11 cases of colon cancer, 18 cases of rectal cancer, and 3 cases of prostate cancer. The youngest is 23 years old and up to 69 years old. Using either 5-FU (1.0 g/day) or FT-207 (1200 mg/day), one of 48 anticancer drugs and corticosteroid chemotherapy combined with VCR (1 to 2 mg/day) and 5-FU (1.0 g/day) Day), FT-207 (1200mg/day),